|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12Q 1/37 | |
| C12Q 1/56 | |||
| C07K 16/40 |
| (11) | Number of the document | 3060582 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14856778.7 |
| Date of filing the European patent application | 2014-10-17 | |
| (97) | Date of publication of the European application | 2016-08-31 |
| (45) | Date of publication and mention of the grant of the patent | 2020-09-23 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/061247 |
| Date | 2014-10-17 |
| (87) | Number | WO 2015/061183 |
| Date | 2015-04-30 |
| (30) | Number | Date | Country code |
| 201361893505 P | 2013-10-21 | US | |
| 201461939837 P | 2014-02-14 | US |
| (72) |
SEXTON, Daniel, J., US
FAUCETTE, Ryan, US
KENNISTON, Jon, A., US
CONLEY, Gregory, P., US
NIXON, Andrew, US
TENHOOR, Christopher, US
ADELMAN, Burt, US
|
| (73) |
Takeda Pharmaceutical Company Limited ,
1-1, Doshomachi 4-chome
Chuo-ku, Osaka-shi, Osaka,
JP
|
| (54) | ASSAYS FOR DETERMINING PLASMA KALLIKREIN SYSTEM BIOMARKERS |
| ASSAYS FOR DETERMINING PLASMA KALLIKREIN SYSTEM BIOMARKERS |